Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2016

01-01-2016 | Gynecologic Oncology

Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer

Authors: Hyo Sook Bae, MD, PhD, Myong Cheol Lim, MD, PhD, Jeong Seon Lee, RN, Yumi Lee, RN, PhDc, Byung Ho Nam, PhD, Sang-Soo Seo, MD, PhD, Sokbom Kang, MD, PhD, Seung Hyun Chung, MD, PhD, Joo-Young Kim, MD, PhD, Sang-Yoon Park, MD, PhD

Published in: Annals of Surgical Oncology | Issue 1/2016

Login to get access

Abstract

Purpose

The goal of this study was to investigate clinical manifestations of lower extremity edema (LEE) after lymph node dissection in patients with primary endometrial cancer.

Methods

Women with primary endometrial cancer who underwent staging surgery between November 2001 and March 2011 were included in the study. Medical records and/or responses to the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) were used for LEE evaluation.

Results

All 154 patients underwent pelvic lymph node dissection, and 126 patients (81.8 %) underwent paraaortic LN dissection. The median age of the patients was 52 years, the majority had stage I cancer (78.6 %), and most had endometrioid histology (90.9 %). The most frequent GCLQ responses were “experienced swelling” (35.7 %), “experienced numbness” (30.5 %), “experienced heaviness” (29.9 %), and “experienced aching” (29.9 %). Sixty-four patients (41.6 %) had previous (9/64, 14.1 %) and/or current (55/64, 85.9 %) patient-reported LEE. Most patients developed LEE within 12 months after surgery (39/56, 69.6 %), and LEE lasted for more than 12 months in most patients (45/56, 80.4 %). Three patients reported recurrent LEE after recovery. Multivariate logistic regression identified the number of dissected pelvic lymph node (≥21) as a risk factor for LEE [odds ratio (OR) 3.28; 95 % confidence interval (CI) 1.058–10.136] and postoperative radiotherapy (OR 3.81, 95 % CI 1.67–8.69).

Conclusions

LEE developed in more than one-third of patients with endometrial cancer after surgery, and LEE lasted for more than 12 months in most patients. A high number of dissected pelvic lymph nodes and postoperative radiotherapy is associated with LEE.
Literature
2.
go back to reference Ministry of Health, W.a.F.A., Cancer Registration Statistics. 2013. Ministry of Health, W.a.F.A., Cancer Registration Statistics. 2013.
6.
go back to reference Beesley V, et al. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer. 2007;109(12):2607–14.PubMedCrossRef Beesley V, et al. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer. 2007;109(12):2607–14.PubMedCrossRef
7.
go back to reference Carter J, et al. A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecol Oncol. 2010;117(2):317–23.PubMedCrossRef Carter J, et al. A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecol Oncol. 2010;117(2):317–23.PubMedCrossRef
8.
go back to reference Lim MC, et al. Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors. Gynecol Oncol. 2014;133(1), 111–16.PubMedCrossRef Lim MC, et al. Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors. Gynecol Oncol. 2014;133(1), 111–16.PubMedCrossRef
9.
go back to reference DiSipio T, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol (Sci Direct). 2013;14(6):500–15.CrossRef DiSipio T, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol (Sci Direct). 2013;14(6):500–15.CrossRef
10.
go back to reference Abu-Rustum NR, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103(2):714–8.PubMedCrossRef Abu-Rustum NR, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103(2):714–8.PubMedCrossRef
12.
go back to reference Bradley S, et al. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol. 2006;100(3):479–486.PubMedCrossRef Bradley S, et al. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol. 2006;100(3):479–486.PubMedCrossRef
13.
go back to reference Janda M, et al. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. (Sci Direct), 2010;11(8):772–80.CrossRef Janda M, et al. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. (Sci Direct), 2010;11(8):772–80.CrossRef
14.
go back to reference Carter BJ. Women’s experiences of lymphedema. Oncol Nurs Forum. 1997;24(5):875–82.PubMed Carter BJ. Women’s experiences of lymphedema. Oncol Nurs Forum. 1997;24(5):875–82.PubMed
15.
go back to reference Todo Y, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119(1):60–4.PubMedCrossRef Todo Y, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119(1):60–4.PubMedCrossRef
16.
go back to reference Nunns D, et al. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma. Int J Gynecol Cancer. 2000;10(3):233–8.PubMedCrossRef Nunns D, et al. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma. Int J Gynecol Cancer. 2000;10(3):233–8.PubMedCrossRef
17.
go back to reference Tada H, et al. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47.PubMedPubMedCentralCrossRef Tada H, et al. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47.PubMedPubMedCentralCrossRef
20.
go back to reference Benedetti Panici P, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707–16. Benedetti Panici P, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707–16.
21.
go back to reference Group AS, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–36.CrossRef Group AS, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–36.CrossRef
22.
go back to reference Todo Y, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165–72.PubMedCrossRef Todo Y, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165–72.PubMedCrossRef
23.
go back to reference Ryan M, et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol. 2003;43(2):148–51.PubMedCrossRef Ryan M, et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol. 2003;43(2):148–51.PubMedCrossRef
24.
go back to reference Hidaka T, et al. Omission of lymphadenectomy is possible for low-risk corpus cancer. Eur J Surg Oncol. 2007;33(1):86–90.PubMedCrossRef Hidaka T, et al. Omission of lymphadenectomy is possible for low-risk corpus cancer. Eur J Surg Oncol. 2007;33(1):86–90.PubMedCrossRef
25.
go back to reference Tanaka T, et al. Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. Int J Gynecol Cancer. 2007;17(2):460–4.PubMedCrossRef Tanaka T, et al. Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. Int J Gynecol Cancer. 2007;17(2):460–4.PubMedCrossRef
26.
go back to reference Han SS, et al. Feasibility of routine lymphadenectomy in clinical stage-I endometrial cancer. Med Sci Monit. 2008;14(4):CR183-9.PubMed Han SS, et al. Feasibility of routine lymphadenectomy in clinical stage-I endometrial cancer. Med Sci Monit. 2008;14(4):CR183-9.PubMed
27.
go back to reference Barnett J.C, et al. Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer. Am J Obstet Gynecol. 2011;205(2):143e1–6.CrossRef Barnett J.C, et al. Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer. Am J Obstet Gynecol. 2011;205(2):143e1–6.CrossRef
28.
go back to reference Konno Y, et al. A retrospective analysis of postoperative complications with or without para-aortic lymphadenectomy in endometrial cancer. Int J Gynecol Cancer. 2011;21(2):385–90.PubMedCrossRef Konno Y, et al. A retrospective analysis of postoperative complications with or without para-aortic lymphadenectomy in endometrial cancer. Int J Gynecol Cancer. 2011;21(2):385–90.PubMedCrossRef
29.
go back to reference Ghezzi F, et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann Surg Oncol. 2012;19(1):259–67.PubMedCrossRef Ghezzi F, et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann Surg Oncol. 2012;19(1):259–67.PubMedCrossRef
30.
go back to reference Backes FJ, et al. Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecol Oncol. 2012;125(3):546–51.PubMedCrossRef Backes FJ, et al. Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecol Oncol. 2012;125(3):546–51.PubMedCrossRef
31.
go back to reference Achouri A, et al. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol. 2013;39(1):81–6.PubMedCrossRef Achouri A, et al. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol. 2013;39(1):81–6.PubMedCrossRef
Metadata
Title
Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer
Authors
Hyo Sook Bae, MD, PhD
Myong Cheol Lim, MD, PhD
Jeong Seon Lee, RN
Yumi Lee, RN, PhDc
Byung Ho Nam, PhD
Sang-Soo Seo, MD, PhD
Sokbom Kang, MD, PhD
Seung Hyun Chung, MD, PhD
Joo-Young Kim, MD, PhD
Sang-Yoon Park, MD, PhD
Publication date
01-01-2016
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 1/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4613-1

Other articles of this Issue 1/2016

Annals of Surgical Oncology 1/2016 Go to the issue